These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21471053)

  • 21. A novel highly charged exopolysaccharide produced by two strains of Stenotrophomonas maltophilia recovered from patients with cystic fibrosis.
    Cescutti P; Cuzzi B; Liut G; Segonds C; Di Bonaventura G; Rizzo R
    Carbohydr Res; 2011 Sep; 346(13):1916-23. PubMed ID: 21636078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a quantitative immunofluorescence assay for detection of Stenotrophomonas maltophilia antibodies in patients with cystic fibrosis.
    Gonçalves Vidigal P; Schmidt D; Stehling F; Mellies U; Steinmann E; Buer J; Rath PM; Steinmann J
    J Cyst Fibros; 2013 Dec; 12(6):651-4. PubMed ID: 23706828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal study of Stenotrophomonas maltophilia antibody levels and outcomes in cystic fibrosis patients.
    Wettlaufer J; Klingel M; Yau Y; Stanojevic S; Tullis E; Ratjen F; Waters V
    J Cyst Fibros; 2017 Jan; 16(1):58-63. PubMed ID: 27346471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis.
    Goss CH; Mayer-Hamblett N; Aitken ML; Rubenfeld GD; Ramsey BW
    Thorax; 2004 Nov; 59(11):955-9. PubMed ID: 15516471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
    Hogardt M; Schmoldt S; Götzfried M; Adler K; Heesemann J
    J Antimicrob Chemother; 2004 Dec; 54(6):1057-61. PubMed ID: 15509615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aerosolized amikacin and oral clarithromycin to eradicate Mycobacterium abscessus in a patient with cystic fibrosis: an 8-year follow-up.
    Colin AA; Ali-Dinar T
    Pediatr Pulmonol; 2010 Jun; 45(6):626-7. PubMed ID: 20503290
    [No Abstract]   [Full Text] [Related]  

  • 27. Emerging cystic fibrosis pathogens: incidence and antimicrobial resistance.
    Magni A; Giordano A; Mancini C; Pecoraro C; Varesi P; Quattrucci S; Trancassini M
    New Microbiol; 2007 Jan; 30(1):59-62. PubMed ID: 17319602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detecting Stenotrophomonas maltophilia does not reduce survival of patients with cystic fibrosis.
    Goss CH; Otto K; Aitken ML; Rubenfeld GD
    Am J Respir Crit Care Med; 2002 Aug; 166(3):356-61. PubMed ID: 12153970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medical devices for cystic fibrosis care may be portable reservoirs of potential pathogens.
    Linnane B; Collins L; Bussmann N; O'Connell NH; Dunne CP
    J Hosp Infect; 2017 Aug; 96(4):397-398. PubMed ID: 28535966
    [No Abstract]   [Full Text] [Related]  

  • 30. Antimicrobial susceptibility profile of molecular typed cystic fibrosis Stenotrophomonas maltophilia isolates and differences with noncystic fibrosis isolates.
    Cantón R; Valdezate S; Vindel A; Sánchez Del Saz B; Maíz L; Baquero F
    Pediatr Pulmonol; 2003 Feb; 35(2):99-107. PubMed ID: 12526070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Community-acquired infection due to Stenotrophomonas maltophilia: a rare cause of meningitis.
    Libanore M; Bicocchi R; Pantaleoni M; Ghinelli F
    Int J Infect Dis; 2004 Sep; 8(5):317-9. PubMed ID: 15325602
    [No Abstract]   [Full Text] [Related]  

  • 32. Infection dynamics of Stenotrophomonas maltophilia in patients with cystic fibrosis.
    Millar BC; McCaughan J; Rendall JC; Moore JE
    J Infect; 2023 Jun; 86(6):626-628. PubMed ID: 36822406
    [No Abstract]   [Full Text] [Related]  

  • 33. Attributable mortality of Stenotrophomonas maltophilia bacteremia.
    Senol E; DesJardin J; Stark PC; Barefoot L; Snydman DR
    Clin Infect Dis; 2002 Jun; 34(12):1653-6. PubMed ID: 12032905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Community-acquired infection due to Stenotrophomonas maltophilia: a rare cause of septic arthritis.
    Aydemir C; Aktaş E; Eldeş N; Kutsal E; Demirel F; Ege A
    Turk J Pediatr; 2008; 50(1):89-90. PubMed ID: 18365601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Stenotrophomonas maltophilia as a cause of hospital infections--typing of clinical isolates using pulsed field gel electrophoresis] ].
    Tripković V; Müller-Premru M; Kalenić S; Plecko V; Jelić I; Filipović-Grcić B; Jandrlić M
    Lijec Vjesn; 2001; 123(9-10):237-41. PubMed ID: 11845578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trimethoprim-sulfamethoxazole in the treatment of Stenotrophomonas maltophilia osteomyelitis.
    Landrum ML; Conger NG; Forgione MA
    Clin Infect Dis; 2005 May; 40(10):1551-2. PubMed ID: 15844086
    [No Abstract]   [Full Text] [Related]  

  • 37. Susceptibility to antimicrobial agents of Stenotrophomonas maltophilia isolated from patients with cancer and bacteremia.
    Krcmery V; Trupl J; Svetlansky I
    Clin Infect Dis; 2001 Jun; 32(11):1656. PubMed ID: 11340542
    [No Abstract]   [Full Text] [Related]  

  • 38. Intralenticular abscess caused by Stenotrophomonas maltophilia.
    Hutchinson K; Kempster R; Conrad D
    Eye (Lond); 2001 Jun; 15(Pt 3):349-50. PubMed ID: 11450743
    [No Abstract]   [Full Text] [Related]  

  • 39. Stenotrophomonas maltophilia intestinal colonization in hospitalized oncology patients with diarrhea.
    Apisarnthanarak A; Fraser VJ; Dunne WM; Little JR; Hoppe-Bauer J; Mayfield JL; Polish LB
    Clin Infect Dis; 2003 Oct; 37(8):1131-5. PubMed ID: 14523780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimizing therapy for Stenotrophomonas maltophilia.
    Muder RR
    Semin Respir Crit Care Med; 2007 Dec; 28(6):672-7. PubMed ID: 18095231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.